Deep Track Capital

Deep Track Capital as of March 31, 2024

Portfolio Holdings for Deep Track Capital

Deep Track Capital holds 65 positions in its portfolio as reported in the March 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Springworks Therapeutics (SWTX) 4.9 $171M 3.5M 49.22
Amgen (AMGN) 4.5 $156M 550k 284.32
Apogee Therapeutics (APGE) 4.4 $154M 2.3M 66.45
Insmed Com Par $.01 (INSM) 3.7 $130M 4.8M 27.13
Dyne Therapeutics (DYN) 3.7 $129M 4.6M 28.39
Alnylam Pharmaceuticals (ALNY) 3.6 $124M 832k 149.45
Guardant Health (GH) 3.5 $124M 6.0M 20.63
Argenx Se Sponsored Adr (ARGX) 3.4 $118M 300k 393.72
Intra Cellular Therapies Put Option (ITCI) 3.3 $116M 1.7M 69.20
Intellia Therapeutics (NTLA) 3.3 $116M 4.2M 27.51
Ocular Therapeutix (OCUL) 3.3 $116M 13M 9.10
Dynavax Technologies Corp Com New (DVAX) 3.2 $113M 9.1M 12.41
Axsome Therapeutics (AXSM) 3.0 $104M 1.3M 79.80
Geron Corporation (GERN) 2.9 $101M 31M 3.30
Autolus Therapeutics Spon Ads (AUTL) 2.8 $97M 15M 6.38
4d Molecular Therapeutics In (FDMT) 2.8 $97M 3.0M 31.86
Alkermes SHS (ALKS) 2.7 $95M 3.5M 27.07
Bicycle Therapeutics Sponsored Ads (BCYC) 2.5 $87M 3.5M 24.90
Pliant Therapeutics (PLRX) 2.5 $86M 5.8M 14.90
Mind Medicine Mindmed Com New (MNMD) 1.8 $63M 6.7M 9.40
Abivax Sa Sponsored Ads (ABVX) 1.8 $62M 4.3M 14.30
Miragen Therapeutics (VRDN) 1.7 $61M 3.5M 17.51
Ionis Pharmaceuticals (IONS) 1.7 $60M 1.4M 43.35
Apellis Pharmaceuticals (APLS) 1.7 $59M 1.0M 58.78
Biosante Pharmaceuticals (ANIP) 1.6 $57M 822k 69.13
Travere Therapeutics (TVTX) 1.6 $57M 7.4M 7.71
Verona Pharma Sponsored Ads (VRNA) 1.5 $51M 3.2M 16.09
Kymera Therapeutics (KYMR) 1.5 $51M 1.3M 40.20
Adagio Therapeutics (IVVD) 1.4 $49M 11M 4.44
Spyre Therapeutics Com New (SYRE) 1.3 $46M 1.2M 37.93
Nurix Therapeutics (NRIX) 1.3 $44M 3.0M 14.70
Hillevax (HLVX) 1.2 $43M 2.6M 16.63
Editas Medicine (EDIT) 1.2 $41M 5.5M 7.42
Fate Therapeutics (FATE) 1.2 $41M 5.6M 7.34
Terns Pharmaceuticals (TERN) 1.1 $40M 6.1M 6.56
Engene Holdings (ENGN) 1.1 $38M 2.3M 16.95
Tourmaline Bio (TRML) 1.0 $37M 1.6M 22.90
Olema Pharmaceuticals (OLMA) 1.0 $37M 3.2M 11.32
Silence Therapeutics Ads (SLN) 1.0 $36M 1.6M 21.60
Pacific Biosciences of California (PACB) 0.8 $26M 7.0M 3.75
Cybin Ord (CYBN) 0.7 $24M 58M 0.41
Alector (ALEC) 0.6 $23M 3.8M 6.02
Nuvalent Inc-a (NUVL) 0.6 $21M 275k 75.09
Agenus Com New 0.5 $18M 32M 0.58
Pyxis Oncology Common Stock (PYXS) 0.5 $18M 4.2M 4.26
Nektar Therapeutics (NKTR) 0.5 $17M 18M 0.93
Immunovant (IMVT) 0.5 $16M 493k 32.31
Neumora Therapeutics (NMRA) 0.4 $14M 1.0M 13.75
Repare Therapeutics Ord (RPTX) 0.4 $13M 2.7M 4.71
Scholar Rock Hldg Corp (SRRK) 0.3 $12M 680k 17.76
Anaptysbio Inc Common (ANAB) 0.3 $12M 530k 22.52
Regulus Therapeutics (RGLS) 0.3 $9.4M 3.3M 2.88
Alto Neuroscience Com Shs (ANRO) 0.3 $9.2M 600k 15.35
Ultragenyx Pharmaceutical (RARE) 0.2 $7.8M 168k 46.69
Zura Bio Class A Ord Shs (ZURA) 0.2 $6.5M 2.5M 2.57
Allakos (ALLK) 0.2 $6.3M 5.0M 1.26
Aligos Therapeutics (ALGS) 0.2 $6.0M 6.1M 0.98
Relmada Therapeutics (RLMD) 0.2 $5.8M 1.2M 4.65
Vigil Neuroscience (VIGL) 0.2 $5.4M 1.6M 3.41
Metagenomi (MGX) 0.1 $4.9M 466k 10.55
Syros Pharmaceuticals Com New (SYRS) 0.1 $4.4M 829k 5.35
Mersana Therapeutics (MRSN) 0.1 $2.6M 580k 4.48
Prime Medicine (PRME) 0.1 $2.1M 304k 7.00
Cogent Biosciences (COGT) 0.1 $2.1M 316k 6.72
Structure Therapeutics Sponsored Ads (GPCR) 0.0 $1.7M 40k 42.86